Bleeding and thrombotic risk of different antiplatelet regimens posttranscatheter edge-to-edge mitral valve repair in patients with an indication for oral anticoagulation: Results from an all-comers national registry.
Marc J ClaeysAdel AminianJozef BartunekJohan BennettIan BuysschaertMathias ClaeysDina De BockLies DelodderPhilippe DebonnaireWillem DewildeBert FerdinandeStéphanie GeerinckKaatje GoetschalckxOlivier LambrechtsStijn LochyBernard P PaelinckLiesbeth RosseelDidier StroobantsMarc VanderheydenJan Van der HeydenPeter VerbruggheStefan VerheyeChristophe DuboisPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
In patients with an indication for OACs, withholding of antiplatelet therapy post-TEER with Mitraclip was associated with a 45% reduction in bleeding and without a signal of increased thrombotic risk.